| abstract |
It refers to a pharmaceutical composition comprising an SSRI (acronym for which it represents the selective serotonin uptake inhibitors) in the form of rapid release and a beta-blocker in the form of sustained release and the use thereof for the production of a drug for the treatment or prevention of alcoholism, anxiety, depression, obsessive compulsive disorder (designated by the acronym OCD), panic disorder, synchronic pain, obesity, senile dementia, migraine, bulimia, anorexia, social phobia, premenstrual syndrome (designated by the acronym PMS), depression of adolescence, trichotillomania, dysthymia and substance abuse. |